RUTHERFORD, N.J., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based diagnostics, today announced its CEO Panna Sharma will present at the following investor conferences:
7th Annual OneMedForumSF 2014, January 13-15, 2014 in San Francisco; CGI will present at 10:30 a.m. PT, Tuesday, January 14
Noble Financial's 10th Annual Equity Conference, January 19-22, 2014 in Sandpiper Bay, Florida; CGI will present at 9:30 a.m. ET, Monday, January 20
About Cancer Genetics:
Cancer Genetics, Inc. is an emerging leader in DNA-based cancer diagnostics, servicing some of the most prestigious medical institutions in the world. Our tests target cancers that are difficult to diagnose and predict treatment outcomes. These cancers include hematological, urogenital and HPV-associated cancers. We also offer a comprehensive range of non-proprietary oncology-focused tests and laboratory services that provide critical genomic information to healthcare professionals, as well as biopharma and biotech companies. Our state-of-the-art reference lab is focused entirely on maintaining clinical excellence and is both CLIA certified and CAP accredited and has licensure from several states including New York State. We have established strong research collaborations with major cancer centers such as Memorial Sloan-Kettering, The Cleveland Clinic, Mayo Clinic and the National Cancer Institute. For further information, please see www.cancergenetics.com.
CONTACT: Investor Relations
RedChip Companies, Inc.Jon Cunningham, 800-733-2447, ext. 107
Source: Cancer Genetics